相似文献
1
Cell and Molecular Processes in Cancer Metastasis: an AJP-Cell Physiology set of Themed Reviews.癌症转移中的细胞与分子过程：《美国生理学杂志-细胞生理学》主题综述集
Am J Physiol Cell Physiol. 2015 Oct 1;309(7):C443. doi: 10.1152/ajpcell.zh0-7813-editorial.2015.
2
Introduction by the Guest Editor: Oligometastatic Disease in Cancer.客座编辑引言：癌症中的寡转移疾病
Cancer J. 2020 Mar/Apr;26(2):95. doi: 10.1097/PPO.0000000000000443.
3
Invasion and metastasis--recent advances and future challenges.侵袭与转移——最新进展与未来挑战
J Mol Med (Berl). 2015 Apr;93(4):361-8. doi: 10.1007/s00109-015-1269-z. Epub 2015 Mar 15.
4
Future perspectives for cancer metastasis and the lymphovascular system.癌症转移与淋巴血管系统的未来展望。
Cancer Metastasis Rev. 2006 Jun;25(2):293-4. doi: 10.1007/s10555-006-8509-1.
5
Critical determinants of metastasis.转移的关键决定因素。
Semin Cancer Biol. 2002 Apr;12(2):89-96. doi: 10.1006/scbi.2001.0416.
6
Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders.正电子发射断层扫描（PET）分子成像在检测和表征原发性及转移部位癌症组织异质性方面不断演变的作用，这是恶性疾病治疗尝试失败的一个合理原因。
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):987-91. doi: 10.1007/s00259-011-1787-z.
7
Metastasis.转移。
Cell. 2023 Apr 13;186(8):1564-1579. doi: 10.1016/j.cell.2023.03.003.
8
Cancer biology still needs physicists.癌症生物学仍需要物理学家。
Nature. 2017 Oct 24;550(7677):431. doi: 10.1038/550431a.
9
Intravital Insights into Heterogeneity, Metastasis, and Therapy Responses.对异质性、转移和治疗反应的活体洞察
Trends Cancer. 2016 Apr;2(4):205-216. doi: 10.1016/j.trecan.2016.03.001. Epub 2016 Mar 28.
10
Antivascular therapy of cancer metastasis.癌症转移的抗血管治疗
J Surg Oncol. 2006 Sep 1;94(3):178-80. doi: 10.1002/jso.20380.
本文引用的文献
1
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.卵巢癌转移中的细胞与分子过程。《癌症转移中的细胞与分子过程》主题综述。
Am J Physiol Cell Physiol. 2015 Oct 1;309(7):C444-56. doi: 10.1152/ajpcell.00188.2015. Epub 2015 Jul 29.
2
STIM and Orai proteins as novel targets for cancer therapy. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.基质相互作用分子（STIM）蛋白和奥拉帕尼蛋白作为癌症治疗的新靶点。《癌症转移中的细胞与分子过程》主题综述。
Am J Physiol Cell Physiol. 2015 Oct 1;309(7):C457-69. doi: 10.1152/ajpcell.00064.2015. Epub 2015 May 27.
3
Metastatic stem cells: sources, niches, and vital pathways.转移性干细胞：来源、微环境及关键通路
Cell Stem Cell. 2014 Mar 6;14(3):306-21. doi: 10.1016/j.stem.2014.02.002.
4
The evolution of the cancer niche during multistage carcinogenesis.癌症微环境在多阶段癌变过程中的演变。
Nat Rev Cancer. 2013 Jul;13(7):511-8. doi: 10.1038/nrc3536. Epub 2013 Jun 13.
5
Targets for anti-metastatic drug development.抗转移药物开发的靶点。
Curr Pharm Des. 2013;19(28):5127-34. doi: 10.2174/1381612811319280011.
6
New promising drug targets in cancer- and metastasis-initiating cells.癌症起始细胞和转移起始细胞中的新的有希望的药物靶点。
Drug Discov Today. 2010 May;15(9-10):354-64. doi: 10.1016/j.drudis.2010.03.009. Epub 2010 Mar 23.
7
Modes of resistance to anti-angiogenic therapy.抗血管生成疗法的耐药模式。
Nat Rev Cancer. 2008 Aug;8(8):592-603. doi: 10.1038/nrc2442.
Zotero 插件